Dr Reddys Laboratories Stock Z Score

RDY Stock  USD 72.31  0.49  0.67%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Dr Reddys Piotroski F Score and Dr Reddys Valuation analysis.
  
At this time, Dr Reddys' Capital Surpluse is fairly stable compared to the past year. Capital Expenditures is likely to rise to about 22.8 B in 2024, whereas Capital Lease Obligations is likely to drop slightly above 1.4 B in 2024. At this time, Dr Reddys' Other Operating Expenses is fairly stable compared to the past year. EBIT is likely to rise to about 116.3 B in 2024, whereas Cost Of Revenue is likely to drop slightly above 44.3 B in 2024.

RDY Z Score Analysis

Dr Reddys' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2021 2022 2023 2024 (projected)
Other Current Liabilities41.6B48.9B56.2B59.0B
Total Assets296.7B322.9B371.3B206.1B

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

Current Dr Reddys Z Score

    
  3.79  
Most of Dr Reddys' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Reddys Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

RDY Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Dr Reddys is extremely important. It helps to project a fair market value of RDY Stock properly, considering its historical fundamentals such as Z Score. Since Dr Reddys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dr Reddys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dr Reddys' interrelated accounts and indicators.
0.970.96-0.071.0-0.14-0.130.920.990.910.98-0.16-0.2-0.050.961.00.990.990.331.00.040.960.03-0.070.19-0.14-0.180.10.030.020.01
0.971.00.090.97-0.04-0.20.970.960.880.95-0.04-0.160.040.910.970.980.960.320.98-0.090.920.11-0.020.12-0.2-0.140.140.140.120.16
0.961.00.160.96-0.01-0.180.970.930.880.920.02-0.120.10.880.960.970.950.30.96-0.150.90.150.040.07-0.18-0.110.130.20.180.2
-0.070.090.16-0.090.7-0.010.17-0.180.03-0.220.880.540.82-0.28-0.08-0.09-0.1-0.16-0.06-0.85-0.260.690.71-0.550.040.4-0.130.810.820.67
1.00.970.96-0.09-0.16-0.130.910.990.90.98-0.18-0.23-0.060.960.990.990.990.320.990.030.960.03-0.060.24-0.14-0.20.10.030.010.0
-0.14-0.04-0.010.7-0.160.08-0.13-0.230.01-0.270.80.640.86-0.28-0.14-0.19-0.17-0.43-0.15-0.75-0.270.710.73-0.340.120.58-0.620.430.490.22
-0.13-0.2-0.18-0.01-0.130.08-0.28-0.120.19-0.150.310.550.01-0.04-0.17-0.16-0.08-0.27-0.170.19-0.14-0.070.14-0.171.00.42-0.52-0.26-0.23-0.25
0.920.970.970.170.91-0.13-0.280.890.770.89-0.03-0.210.030.810.920.930.90.410.93-0.120.850.11-0.08-0.01-0.27-0.140.310.250.230.3
0.990.960.93-0.180.99-0.23-0.120.890.891.0-0.26-0.26-0.170.980.990.990.980.360.980.160.99-0.1-0.170.27-0.14-0.230.13-0.1-0.12-0.06
0.910.880.880.030.90.010.190.770.890.870.070.140.020.90.890.890.910.130.880.030.870.060.140.170.19-0.02-0.09-0.02-0.01-0.02
0.980.950.92-0.220.98-0.27-0.150.891.00.87-0.31-0.3-0.210.980.980.990.980.380.980.190.99-0.13-0.230.29-0.17-0.250.16-0.13-0.15-0.07
-0.16-0.040.020.88-0.180.80.31-0.03-0.260.07-0.310.850.72-0.32-0.19-0.2-0.18-0.35-0.18-0.7-0.320.70.76-0.490.360.68-0.30.60.640.48
-0.2-0.16-0.120.54-0.230.640.55-0.21-0.260.14-0.30.850.4-0.26-0.23-0.24-0.23-0.34-0.24-0.26-0.270.380.59-0.340.60.75-0.330.180.210.16
-0.050.040.10.82-0.060.860.010.03-0.170.02-0.210.720.4-0.24-0.06-0.11-0.07-0.37-0.04-0.9-0.240.690.76-0.450.040.34-0.530.640.70.3
0.960.910.88-0.280.96-0.28-0.040.810.980.90.98-0.32-0.26-0.240.950.960.970.240.940.240.98-0.16-0.190.38-0.06-0.290.07-0.2-0.22-0.14
1.00.970.96-0.080.99-0.14-0.170.920.990.890.98-0.19-0.23-0.060.950.990.980.351.00.050.960.02-0.10.19-0.18-0.190.120.020.010.0
0.990.980.97-0.090.99-0.19-0.160.930.990.890.99-0.2-0.24-0.110.960.990.990.350.990.080.97-0.03-0.130.22-0.17-0.210.16-0.02-0.040.03
0.990.960.95-0.10.99-0.17-0.080.90.980.910.98-0.18-0.23-0.070.970.980.990.240.980.040.960.02-0.070.24-0.09-0.220.070.01-0.010.0
0.330.320.3-0.160.32-0.43-0.270.410.360.130.38-0.35-0.34-0.370.240.350.350.240.350.30.37-0.34-0.47-0.16-0.29-0.010.51-0.11-0.20.02
1.00.980.96-0.060.99-0.15-0.170.930.980.880.98-0.18-0.24-0.040.941.00.990.980.350.020.950.05-0.080.18-0.18-0.190.130.060.050.03
0.04-0.09-0.15-0.850.03-0.750.19-0.120.160.030.19-0.7-0.26-0.90.240.050.080.040.30.020.24-0.82-0.770.350.15-0.250.3-0.82-0.84-0.47
0.960.920.9-0.260.96-0.27-0.140.850.990.870.99-0.32-0.27-0.240.980.960.970.960.370.950.24-0.19-0.220.33-0.16-0.250.15-0.2-0.23-0.12
0.030.110.150.690.030.71-0.070.11-0.10.06-0.130.70.380.69-0.160.02-0.030.02-0.340.05-0.82-0.190.7-0.17-0.030.42-0.260.780.820.45
-0.07-0.020.040.71-0.060.730.14-0.08-0.170.14-0.230.760.590.76-0.19-0.1-0.13-0.07-0.47-0.08-0.77-0.220.7-0.080.170.26-0.390.640.640.32
0.190.120.07-0.550.24-0.34-0.17-0.010.270.170.29-0.49-0.34-0.450.380.190.220.24-0.160.180.350.33-0.17-0.08-0.21-0.570.08-0.35-0.4-0.29
-0.14-0.2-0.180.04-0.140.121.0-0.27-0.140.19-0.170.360.60.04-0.06-0.18-0.17-0.09-0.29-0.180.15-0.16-0.030.17-0.210.46-0.52-0.22-0.19-0.21
-0.18-0.14-0.110.4-0.20.580.42-0.14-0.23-0.02-0.250.680.750.34-0.29-0.19-0.21-0.22-0.01-0.19-0.25-0.250.420.26-0.570.46-0.270.130.150.04
0.10.140.13-0.130.1-0.62-0.520.310.13-0.090.16-0.3-0.33-0.530.070.120.160.070.510.130.30.15-0.26-0.390.08-0.52-0.270.130.040.28
0.030.140.20.810.030.43-0.260.25-0.1-0.02-0.130.60.180.64-0.20.02-0.020.01-0.110.06-0.82-0.20.780.64-0.35-0.220.130.130.970.76
0.020.120.180.820.010.49-0.230.23-0.12-0.01-0.150.640.210.7-0.220.01-0.04-0.01-0.20.05-0.84-0.230.820.64-0.4-0.190.150.040.970.68
0.010.160.20.670.00.22-0.250.3-0.06-0.02-0.070.480.160.3-0.140.00.030.00.020.03-0.47-0.120.450.32-0.29-0.210.040.280.760.68
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

Based on the company's disclosures, Dr Reddys Laboratories has a Z Score of 3.79. This is 43.85% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The z score for all United States stocks is 56.54% higher than that of the company.

RDY Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Reddys' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dr Reddys could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics of similar companies.
Dr Reddys is currently under evaluation in z score category among related companies.

Dr Reddys Institutional Holders

Institutional Holdings refers to the ownership stake in Dr Reddys that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Dr Reddys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Dr Reddys' value.
Shares
Gqg Partners Llc2023-12-31
437 K
Ameriprise Financial Inc2023-09-30
434.5 K
Millennium Management Llc2023-09-30
361.6 K
Grantham, Mayo, Van Otterloo & Co., Llc2023-12-31
329.1 K
Lazard Asset Management Llc2023-09-30
306.1 K
Acadian Asset Management Llc2023-09-30
270.3 K
Schroder Investment Management Group2023-12-31
266.7 K
Mondrian Investment Partners Ltd2023-09-30
216.1 K
Assenagon Asset Management Sa2023-12-31
196.1 K
Blackrock Inc2023-12-31
M
Royal Bank Of Canada2023-09-30
2.1 M

RDY Fundamentals

About Dr Reddys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dr Reddys Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Reddys Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 24795 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dr Reddys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dr Reddys' short interest history, or implied volatility extrapolated from Dr Reddys options trading.

Currently Active Assets on Macroaxis

When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out Dr Reddys Piotroski F Score and Dr Reddys Valuation analysis.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEOs Directory
Screen CEOs from public companies around the world
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.75
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.